Click here to order an original    

copy with the contact addresses.

NOT FOR REPRINT © 2001

In the summer of 1986 Medizone obtained from the FDA an IND (Investigative New Drug) Approval for ozone, which falls under the heading of drugs even though it isn't. They verified that ozone destroys the AIDS virus in vitro, and completed their animal tests in the fall of 1986. The tests demonstrated no indication of toxicity, at ten times the equivalent amount that is proposed for human treatment.

The Medizone Co at: Click here to purchase original copies for contact addresses and telephone numbers
 
Medizone says that it has obtained the rights to US patent #4,632,980, on "ozonation of blood and blood
products", from the company "Immunologics", in exchange for Medizone stock shares. The patent pertains specifically to inactivating lipid-envelope virus. In humans, this includes AIDS, herpes, hepatitis, Epstein Barr virus, and cytomegalovirus, among others. Medizone obtained tentative FDA approval in April 1987 to begin human testing, but for a variety of "bureaucratic reasons" the FDA has postponed the actual start of the tests eight times now, with requests for further data, some of which had already been given to them.

Twenty months now have passed [as of December 1988], along with several thousand AIDS victims, since the first announced starting date was postponed. The Medizone staff is hoping to finally begin in the spring of 1989, but are no longer announcing expected starting dates with much confidence. "There are no technical problems, but this is the FDA we're dealing with, after all." As the Company's future hangs on their decision, no one at Medizone wants to risk antagonizing the FDA, by speculating about their actual motives for stalling such a broad-spectrum cure.

All this can be done with virtually no publicity. The official reason for is that the accepted procedure for publishing medical breakthroughs is to complete all the tests first, even though victims may die waiting for the cautious, methodical testing procedure to run its course. No one in the industry wants to raise false hopes, let alone repeat the medical disasters that have resulted in the past, from rushing approval on new treatments.

On the other hand, the enormously expensive and dubiously effective drug AZT was widely publicized and many months before it was approved in the US, as is ongoing research into possible AIDS vaccines. In fact, FDA Commissioner Frank Young has even announced a proposal to make experimental drugs available to AIDS victims as swiftly as possible, without waiting for full FDA approval procedure to be completed. So there appears to be a sever double standard involved here. It seems that highly
profitable "treatments" with serious side effects can be promoted through massive news coverage, while an actual cure, repeatedly demonstrated in Europe, with minimal cost and no apparent harmful effects, must be delayed and kept quiet while panic and deaths mount. Surely at this stage the benefits of unauthorized publicity will outweigh the risks.

Click here for to view 

5. "SAFE PURIFICATION OF BLOOD FOR TRANSFUSIONS